Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients

NCT04817241 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

5

Enrollment

NIH

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
DRUG: Cytarabine
DRUG: Daunorubicin
DRUG: Decitabine and Cedazuridine
DRUG: Venetoclax

Sponsor

National Cancer Institute (NCI)